Skip to main content

John Marshall

John is the Evidence Lead for the NHS Screening Programmes. He has worked for the UK National Screening Committee since 2003 and helped establish the evidence team in 2013.

New format to UK NSC consultations starts with 5 newborn blood spot conditions

The UK National Screening Committee (UK NSC) makes recommendations on all aspects of population screening. We make recommendations on more than 100 conditions, including recommendations to screen for more than 30.

Evidence update: new consultation on non-invasive prenatal testing and latest UK NSC recommendations

Posted by: , Posted on: - Categories: UK National Screening Committee

Non-invasive prenatal testing (now more commonly called cfDNA, or cell-free DNA testing) is an exciting development and the UK NSC is now consulting on introducing it to the existing fetal anomaly screening programme (FASP). As new technology can only be introduced …